Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: Results from the Phase 2b CONTROL study.
Christopher G BunickJoyce M C TengScott GuenthnerKalyani MaratheSteven KempersKimmie EadsLeslie Castelo-SoccioAlan M MendelsohnJessica RaizDedee Frances MurrellPublished in: Clinical and experimental dermatology (2023)
Higher DLQI and I-NRS scores at baseline were associated with participants achieving treatment success by VIIS-50 and IGA response. Lower BSA involvement was associated with VIIS-50 success.